Related Experiment Video
Updated: Jul 27, 2025
08:53
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
Published on: August 31, 2016
15.3K
Transplanting candidates with stacked risks negatively affects outcomes.
Edward Cantu1, Dun Jin1, Madeline McCurry1
1Division of Cardiovascular Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Summary
Increased comorbidities in lung transplant recipients worsen outcomes, including higher mortality, longer hospital stays, and increased costs. Understanding these stacked risks is crucial for improving patient care after lung transplantation.
Area of Science:
- Medical research
- Transplant surgery
- Health outcomes analysis
Background:
- Lung transplant (LT) centers face increasing numbers of patients with multiple risk factors.
- The impact of accumulated risks on post-transplant outcomes is not well understood.
- Evaluating the relationship between comorbidity burden and patient outcomes is essential.
Purpose of the Study:
- To determine the association between the number of comorbidities and post-lung transplant outcomes.
- To quantify the impact of stacked risks on mortality, length of stay, and hospital charges.
- To analyze the effect of comorbidity count on patient discharge disposition.
Main Methods:
- Retrospective cohort study using the National Inpatient Sample (NIS) and UNOS Starfile (USF) databases (2016-2019).
- Probabilistic matching algorithm applied to link patient records.
- Elixhauser methodology used to identify comorbidities; penalized cubic splines, Kaplan-Meier, and regression analyses employed.
Main Results:
- A total of 1,821 lung transplant recipients were analyzed.
- Comorbidity groups (low <3, medium 3-6, high >6) showed significant differences in outcomes.
- Inpatient mortality (1.6% to 7.0%), length of stay (16 to 29 days), total charges, and skilled nursing facility discharge rates increased with higher comorbidity counts.
Conclusions:
- Accumulated comorbidities (stacked risks) negatively impact post-lung transplant mortality, length of stay, and hospital charges.
- Higher comorbidity burden is associated with increased likelihood of discharge to a skilled nursing facility.
- Further research is needed to elucidate the specific effects of various stacked risks in lung transplant recipients.
Related Concept Videos
01:24Tissue Transplantation
417
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
417
01:28Kidney Transplant I: Introduction
29
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
01:22Bone Marrow Sampling and Transplants
364
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
364
01:26Kidney Transplant II: Surgical Procedure
37
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
37
01:16Kidney Transplant III: Nursing Management
41
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
41
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
150
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
150